EnligHTN™ Renal Denervation System

DEVICE2 trials

Sponsors

Abbott Medical Devices, Institute Arnault Tzanck, France

Conditions

Chronic Heart FailureUncontrolled Hypertension

Phase 1

Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance Cardiaque

Institute Arnault Tzanck, FranceChronic Heart Failure

Start: 2017-01-31End: 2018-01-31Target: 12Updated: 2016-10-19

Unknown Phase

Observational Study of the EnligHTN Renal Denervation System in Europe

CompletedNCT02006758

Abbott Medical DevicesUncontrolled Hypertension

Start: 2013-11-30End: 2017-05-31Updated: 2019-10-16